Neurocardiogenic syncope epidemiology and demographics: Difference between revisions
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{Neurocardiogenic syncope}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Neurocardiogenic syncope is the most common cause of syncope in children and adults. | Neurocardiogenic syncope is the most common cause of [[syncope]] in children and adults and accounts for approximately 10-40% of all syncopal episodes. | ||
==Incidence== | ==Incidence== | ||
The prevalence is 22% in the general population. Approximately 50%-66% of syncope cases are classified as due to vasovagal syncope. | The prevalence is 22% in the general population. Approximately 50%-66% of syncope cases are classified as due to vasovagal syncope. | ||
==References== | |||
{{reflist|2}} | |||
[[Category:Cardiology]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Latest revision as of 12:43, 17 May 2012
|
Neurocardiogenic Syncope Microchapters |
|
Differentiating Neurocardiogenic Syncope From Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Neurocardiogenic syncope epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Neurocardiogenic syncope epidemiology and demographics |
|
FDA on Neurocardiogenic syncope epidemiology and demographics |
|
CDC on Neurocardiogenic syncope epidemiology and demographics |
|
Neurocardiogenic syncope epidemiology and demographics in the news |
|
Blogs on Neurocardiogenic syncope epidemiology and demographics |
|
Risk calculators and risk factors for Neurocardiogenic syncope epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Neurocardiogenic syncope is the most common cause of syncope in children and adults and accounts for approximately 10-40% of all syncopal episodes.
Incidence
The prevalence is 22% in the general population. Approximately 50%-66% of syncope cases are classified as due to vasovagal syncope.